$CLSN initiated with Outperform rating and $9 (321% upside) price target by Oppenheimer based on the expected success of a Phase 3. Shares are up 36% #premarket on robust volume. #stocks#investing#tradeideas#trading
Sunesis Pharmaceuticals $SNSS initiated with Outperform rating and $7 (144% upside) price target by Oppenheimer. Shares up 8% premarket. #stocks#investing#tradeideas#trading
I think $T has sold off more than it should last quarter anyway. Right now, the market seems to be reacting that if the merger is blocked, it is good for $T. Either way I am buying it in the $34 range. #stocks#investing#tradeideas#trading
I own a large amount of $TTWO. I am expecting a 15%-30% return next year on them. This last year I have a 50% return on them. #stocks#investing#tradeideas#trading
$TSLA I learned the hard way to never trade with emotion. Cut losses and recoup. But then again, #tesla is like the only stock that goes up when it shouldnโt. #stocks#investing#tradeideas#trading
$KTOV jumps 20% premarket on increased volume. No particular news accounts for the action other that an upgrade by nano cap uber-bull H.C. Wainwright to Buy with a $10 (408% upside) price target. #stocks#investing#tradeideas#trading
$TSRO, European approval for drug.. $CZZ, $200M buyback plan.. $BIVV, low volume gap down thru 200dma. $LTUM, for Pink Sheeters #stocks#investing#tradeideas#trading
GBH Insights analyst Daniel Ives says Amazon $AMZN will have a โblowoutโ holiday quarter with Prime members spending 20% to 25% more this season. #stocks#investing#tradeideas#trading